2024 annual financial data
Akebia Therapeutics 2024 Operating margin
Direct answer
Operating margin was -31.51%.
Operating income was -50,472,000 USD and net income was -69,410,000 USD.
Operating cash flow was -40,659,000 USD.
Get free Akebia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 160,180,000 USD
- Operating income
- -50,472,000 USD
- Net income
- -69,410,000 USD
- Operating cash flow
- -40,659,000 USD